openPR Logo
Press release

Warts Therapeutics Market Size Report 2032 | Veloce BioPharma LLC, Nielsen BioSciences, Inc., ViroXis Corporation, Aclaris Therapeutics

03-10-2025 08:05 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Warts Market

Warts Market

DelveInsight's "Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Warts, historical and forecasted epidemiology as well as the Warts market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover Key Insights into the Warts Market with DelveInsight's In-Depth Report @ Warts Market Size- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Warts Market Report
• In February 2025:- Merck Sharp & Dohme LLC conducted a randomized, worldwide, placebo-controlled, double-blind study to evaluate the safety, immunogenicity, and efficacy of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine. The study, known as FUTURE II (Females United to Unilaterally Reduce Endo/Ectocervical Disease), aims to assess the vaccine's impact on the incidence of HPV 16/18-related CIN 2/3 or worse in women aged 16 to 23 years.
• In February 2025:- LEO Pharma conducted a trial to explore the safety, tolerability, and efficacy of Picato® 0.05% gel in the treatment of genital warts (GW). The primary outcome measures focus on safety and tolerability, including the severity of local reactions in the treated area, as well as treatment-related adverse events (AEs) and serious adverse events (SAEs).
• In February 2025:- Nielsen BioSciences Inc. conducted a study comparing an equal volume injection of Candin with a placebo (unpreserved normal saline solution) for the treatment of common warts. Participants will be randomized in a 2:1 ratio to receive either Candin or placebo. During the treatment period, a 0.5 mL dose of the investigational product will be injected every two weeks into a single wart until either clinical clearance is achieved or a total of 10 injections have been administered.
• The leading Warts Companies such as Veloce BioPharma LLC, Nielsen BioSciences, Inc., ViroXis Corporation, Aclaris Therapeutics, Inc. and others.
• Promising Warts Therapies such as CANDIN, A-101, KNP2002, Resiquimod, and others.

Stay ahead in the Warts Therapeutics Market with DelveInsight's Strategic Report @ Warts Market Outlook- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Warts Epidemiology Insights
The epidemiology section of Warts offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Warts Epidemiology trends @ Warts Epidemiological Insights- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Warts Drugs Market
The Warts Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Warts signaling in Warts are likely to uncover new therapeutic targets and further expand treatment options for patients.

Warts Treatment Market Landscape
The Warts treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Warts has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Warts treatment guidelines, visit @ Warts Treatment Market Landscape- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Warts Market Outlook
The report's outlook on the Warts market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Warts therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Warts drug and late-stage pipeline therapy.

Warts Drugs Uptake
The drug chapter of the Warts report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Warts.

Major Warts Companies
Veloce BioPharma LLC, Nielsen BioSciences, Inc., ViroXis Corporation, Aclaris Therapeutics, Inc. and others.

Learn more about the FDA-approved drugs for Warts @ Drugs for Warts Treatment- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Warts Market Report
• Coverage- 7MM
• Warts Companies- Veloce BioPharma LLC, Nielsen BioSciences, Inc., ViroXis Corporation, Aclaris Therapeutics, Inc. and others.
• Warts Therapies- CANDIN, A-101, KNP2002, Resiquimod, and others.
• Warts Market Dynamics: Warts Market Drivers and Barriers
• Warts Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Warts Drugs in development @ Warts Clinical Trials Assessment- https://www.delveinsight.com/sample-request/warts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Report Introduction
3. Warts Market Overview at a Glance
4. Executive Summary of Warts
5. Key Events
6. Epidemiology and Market Methodology
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Emerging Therapies
12. Warts: Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

List of Top Selling Market Research Reports in 2025

Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market
Medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Warts Therapeutics Market Size Report 2032 | Veloce BioPharma LLC, Nielsen BioSciences, Inc., ViroXis Corporation, Aclaris Therapeutics here

News-ID: 3906380 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Warts

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts …
The Genital Warts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Genital Warts Market Size and Projected Growth Rate? The genital warts market has grown strongly in recent years. It is set to increase from $1.97 billion in 2024 to $2.08 billion in
Warts Therapeutics Market Report 2024 - Warts Therapeutics Market Insights, Grow …
"The Business Research Company recently released a comprehensive report on the Global Warts Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Genital Warts Market - Revolutionizing Intimate Care: Transforming the Genital W …
Newark, New Castle, USA: The "Genital Warts Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Genital Warts Market: https://www.growthplusreports.com/report/genital-warts-market/8677 This latest report researches the industry structure, sales, revenue,
Common Warts Treatment Market - Winning the Battle Against Common Warts: Leading …
Newark, New Castle, USA: The "Common Warts Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Common Warts Treatment Market: https://www.growthplusreports.com/report/common-warts-treatment-market/8672 This latest report researches the industry structure,
Warts Therapeutics Market Analysis and Outlook Report 2030
Warts Therapeutics Market: Introduction According to the report, the global warts therapeutics market was valued at US$ 1.7 Bn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could predictably resolve warts in a few weeks with minimal side effects. Topical treatment of may